Elena Ioana Braicu

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Gene expression markers in peripheral blood and outcome in patients with platinum‐resistant ovarian cancer: A study of the European GANNET53 consortium”.

Gene expression markers in peripheral blood and outcome in patients with platinum‐resistant ovarian cancer: A study of the European GANNET53 consortium

International Journal of Cancer(2024)10.1002/ijc.34978

N/A

0DataRank · unranked

3 citations

Thomas Mohr, Eva Schuster, Elena Ioana Braicu, Eliane T. Taube, Jalid Sehouli +11 more

1223TiP A randomized phase III study of first-line (1L) trastuzumab deruxtecan (T-DXd) with rilvegostomig or pembrolizumab in patients with HER2-expressing, mismatch repair-proficient (pMMR), primary advanced or recurrent endometrial cancer (EC): DESTINY-Endometrial01/GOG-3098/ENGOT-EN24

Annals of Oncology(2025)10.1016/j.annonc.2025.08.1858

N/A

0DataRank · unranked

1 citations

P. Follana, Melissa A. Geller, Elena Ioana Braicu, S. Ghamande, Ignacio A. Romero +13 more